Cargando…
Targeting LRH-1/NR5A2 to treat type 1 diabetes mellitus
Type 1 diabetes mellitus (T1DM) is defined as an autoimmune disease that targets the selective destruction of islet insulin-producing beta cells by infiltrating immune cells (insulitis). As a result, the organism is no longer able to produce insulin and develops hyperglycaemia and, if untreated, dea...
Autores principales: | Cobo-Vuilleumier, Nadia, Lorenzo, Petra I., Gauthier, Benoit R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shared Science Publishers OG
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551680/ https://www.ncbi.nlm.nih.gov/pubmed/31225479 http://dx.doi.org/10.15698/cst2018.06.140 |
Ejemplares similares
-
NR5A2/LRH-1 regulates the PTGS2-PGE(2)-PTGER1 pathway contributing to pancreatic islet survival and function
por: Martin Vázquez, Eugenia, et al.
Publicado: (2022) -
LRH-1 agonism favours an immune-islet dialogue which protects against diabetes mellitus
por: Cobo-Vuilleumier, Nadia, et al.
Publicado: (2018) -
Targeting FBXO44/SUV39H1 elicits tumor cell-specific DNA replication stress and viral mimicry
por: Shen, Jia Z., et al.
Publicado: (2021) -
P4HA1 is a new regulator of the HIF-1 pathway in breast cancer
por: Xu, Ren
Publicado: (2019) -
A pathological role of the Hsp40 protein Ydj1/DnaJA1 in models of Alzheimer’s disease
por: Tadic, Jelena, et al.
Publicado: (2022)